The DOI matches its Crossref record; 198 of the 198 references it cites were found in a registry or an index.
The metabolic basis of epilepsy
Open accessAbstract
The brain is a highly energy-demanding organ and requires bioenergetic adaptability to balance normal activity with pathophysiological fuelling of spontaneous recurrent seizures, the hallmark feature of the epilepsies. Recurrent or prolonged seizures have long been known to permanently alter neuronal circuitry and to cause excitotoxic injury and aberrant inflammation. Furthermore, pathological changes in bioenergetics and metabolism are considered downstream consequences of epileptic seizures that begin at the synaptic level. However, as we highlight in this Review, evidence is also emerging that primary derangements in cellular or mitochondrial metabolism can result in seizure genesis and lead to spontaneous recurrent seizures. Basic and translational research indicates that the relationships between brain metabolism and epileptic seizures are complex and bidirectional, producing a vicious cycle that compounds the deleterious consequences of seizures. Metabolism-based treatments such as the high-fat, antiseizure ketogenic diet have become mainstream, and metabolic substrates and enzymes have become attractive molecular targets for seizure prevention and recovery. Moreover, given that metabolism is crucial for epigenetic as well as inflammatory changes, the idea that epileptogenesis can be both negatively and positively influenced by metabolic changes is rapidly gaining ground. Here, we review evidence that supports both pathophysiological and therapeutic roles for brain metabolism in epilepsy. In this Review, the authors highlight the growing recognition that disruptions in cellular metabolism can be both a cause and a consequence of epileptic seizures and discuss how this emerging science might be exploited to develop innovative therapeutic strategies. Epileptic seizures induce widespread derangements in cellular and mitochondrial metabolism, as well as cerebral flood flow. Primary defects in genes that encode mitochondrial proteins and/or metabolic substrates and enzymes can increase neuronal and glial network excitability. Brain metabolic homeostasis and function can be viewed as an interplay among the cerebral circulation, glia and neurons, also known as the neurovascular unit. Epilepsy can be viewed as a metabolic disease, and primordial mechanisms evoked by compounds such as adenosine could be highly relevant to seizures and epileptogenesis. Metabolism-based treatments such as the high-fat ketogenic diet and its variants can help to restore metabolic homeostasis and enable seizure control. As dietary therapies can often control seizures in individuals with medically intractable epilepsy, experimental therapeutics based on metabolic targets should be explored. Epileptic seizures induce widespread derangements in cellular and mitochondrial metabolism, as well as cerebral flood flow. Primary defects in genes that encode mitochondrial proteins and/or metabolic substrates and enzymes can increase neuronal and glial network excitability. Brain metabolic homeostasis and function can be viewed as an interplay among the cerebral circulation, glia and neurons, also known as the neurovascular unit. Epilepsy can be viewed as a metabolic disease, and primordial mechanisms evoked by compounds such as adenosine could be highly relevant to seizures and epileptogenesis. Metabolism-based treatments such as the high-fat ketogenic diet and its variants can help to restore metabolic homeostasis and enable seizure control. As dietary therapies can often control seizures in individuals with medically intractable epilepsy, experimental therapeutics based on metabolic targets should be explored.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sokoloff, L., Reivich, M., Kennedy, C., Rosiers, M. H. D., Patlak, C. S., Pettigrew, K. D., Sakurada, O., & Shinohara, M. (1977) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1977.tb10649.x · Cited by 6,000
Pellerin, L., & Magistretti, P. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.22.10625 · Cited by 2,927
Brain energy metabolism: focus on Astrocyte-neuron metabolic cooperation
Bélanger, M., Allaman, I., & Magistretti, P. J. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.08.016 · Cited by 2,313
The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease
Youm, Y.-H., Nguyen, K. Y., Grant, R. W., Goldberg, E. L., Bodogai, M., Kim, D., D'Agostino, D., Planavsky, N., Lupfer, C., Kanneganti, T. D., et al. (2015) · Nature Medicine · doi:10.1038/nm.3804 · Cited by 2,172
The role of inflammation in epilepsy
Vezzani, A., French, J., Bartfai, T., & Baram, T. Z. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.178 · Cited by 1,876
Suppression of Oxidative Stress by β-Hydroxybutyrate, an Endogenous Histone Deacetylase Inhibitor
Shimazu, T., Hirschey, M. D., Newman, J., He, W., Shirakawa, K., Le Moan, N., Grueter, C. A., Lim, H., Saunders, L. R., Stevens, R. D., et al. (2013) · Science · doi:10.1126/science.1227166 · Cited by 1,777
Benzodiazepine Receptor: Demonstration in the Central Nervous System
Möhler, H., & Okada, T. (1977) · Science · doi:10.1126/science.918669 · Cited by 1,700
Brain Metabolism during Fasting*
Owen, O. E., Morgan, A. P., Kemp, H. G., Sullivan, J. M., Herrera, M. G., & Cahill, G. F. (1967) · Journal of Clinical Investigation · doi:10.1172/jci105650 · Cited by 1,646
The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam
Lynch, B. A., Lambeng, N., Nocka, K., Kensel-Hammes, P., Bajjalieh, S. M., Matagne, A., & Fuks, B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308208101 · Cited by 1,610
Multi-dimensional Roles of Ketone Bodies in Fuel Metabolism, Signaling, and Therapeutics
Puchalska, P., & Crawford, P. A. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2016.12.022 · Cited by 1,610
Cited by
mTOR and neuroinflammation in epilepsy: implications for disease progression and treatment
Ravizza, T., Scheper, M., Di Sapia, R., Gorter, J., Aronica, E., & Vezzani, A. (2024) · Nature Reviews Neuroscience · doi:10.1038/s41583-024-00805-1 · Cited by 141
Properties of REM sleep alterations with epilepsy
Ikoma, Y., Takahashi, Y., Sasaki, D., & Matsui, K. (2023) · Brain · doi:10.1093/brain/awac499 · Cited by 33
Local brain environment changes associated with epileptogenesis
Ikoma, Y., Sasaki, D., & Matsui, K. (2023) · Brain · doi:10.1093/brain/awac355 · Cited by 26
Glycolytic lactate production supports status epilepticus in experimental animals
Skwarzynska, D., Sun, H., Kasprzak, I., Sharma, S., Williamson, J., & Kapur, J. (2023) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51881 · Cited by 11
Metadata
- Authors
- Rho, J. M., & Boison, D.
- Venue
- Nature Reviews Neurology
- Published
- 2022-03-31
- Volume
- 18
- Issue
- 6
- Pages
- 333-347
- ISSN
- 1759-4758 (ISSN-L)
- 1759-4766
- OpenAlex
- W4220970567
- Cited by
- 295
- References
- 198
- FWCI
- 11.92
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The metabolic basis of epilepsy. https://app.cochat.ai/papers/10.1038/s41582-022-00651-8
- The paper
- Rho, J. M., & Boison, D. (2022). The metabolic basis of epilepsy. Nature Reviews Neurology. https://doi.org/10.1038/s41582-022-00651-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.